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Prospective Comparison of Collagen Plug
(Angio-Seal
TM) and Suture-Mediated 
(the Closer S
TM) Closure Devices at
Femoral Access Sites
Objective: Rapid and effective hemostasis at femoral puncture sites minimizes
both the hospital stay and patient discomfort. Therefore, a variety of arterial clo-
sure devices have been developed to facilitate the closure of femoral arteriotomy.
The objective of this prospective study was to compare the efficacy of two differ-
ent closure devices; a collagen plug device (Angio-Seal) and a suture-mediated
closure device (the Closer S). 
Materials and Methods: From March 28, 2003 to August 31, 2004, we con-
ducted a prospective study in which 1,676 cases of 1,180 patients were treated
with two different types of closure device. Angio-Seal was used in 961 cases and
the Closer S in 715 cases. The efficacy of the closure devices was assessed, as
well as complications occurring at the puncture sites. 
Results: Successful immediate hemostasis was achieved in 95.2% of the
cases treated with Angio-Seal, and in 89.5% of the cases treated with the Closer
S (p < 0.05). The rates of minor and major complications occurring between the
two groups were not significantly different. In the Closer S group, we observed
four major complications (0.6%), that consisted of one massive retroperitoneal
hemorrhage (surgically explored) and three pseudoaneurysms. In the Angio-Seal
group, we observed three major complications (0.3%) that consisted of one
femoral artery occlusion, one case of infection treated with intravenous antibiotics
and one pseudoaneurysm. 
Conclusion: The use of Angio-Seal was found to be more effective than that of
the Closer S with regard to the immediate hemostasis of the femoral puncture
sites. However, we detected no significant differences in the rate at which compli-
cations occurred.
emostasis after gaining arterial access for diagnostic and interventional
catheterization has classically been accomplished by performing manual
compression of the punctured artery. However, this necessitates
prolonged periods of bed rest following sheath removal. In previous studies, an arterial
closure device was proven to improve patient comfort, decrease the time to ambula-
tion and shorten the patients’ hospital stay as compared with simple manual compres-
sion (1-5).
Angio-Seal is an arterial closure device that involves a collagen plug and an intra-
arterial anchor. The arteriotomy site is positioned between them like the filling of a
sandwich, and the collagen induces coagulation. This method has been proven
effective in reducing the time to hemostasis and ambulation, subsequent to both
transfemoral angiography and intervention (1-6). The Closer S is a kind of percuta-
neous suture closure device that has demonstrated a relatively high hemostasis efficacy
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Hrate (7-11). To the best of our knowledge, there have been
no prospective studies that have compared the Angio-Seal
and the Closer S devices. This trial is the first prospective
study to compare the efficacy, device failure rates and
complication rates of the two devices during both
angiographic and interventional procedures.
MATERIALS AND METHODS
Device and Procedure
Angio-Seal is a collagen-based vascular hemostasis
device that utilizes an absorbable intravascular polymer
anchor and an extravascular collagen sponge that are
connected by an absorbable positioning suture. The Closer
S is a suture-mediated vascular hemostasis device that
consists of one nonabsorbable polypropylene surgical
suture, which forms a square knot on the arterial surface.
In all the patients, the closure of femoral arteriotomy
was performed in the catheterization laboratory immedi-
ately after a transfemoral interventional procedure. The
exclusion criteria for the application of a closure device
included difficulty in puncturing the artery, severe periph-
eral vascular disease, marked obesity, an age < 15 years,
the arterial sheath size < 4 French or > 8 French and the
patient’s refusal to provide a written informed consent. In
order to initiate the deployment of the device, we used a
guidewire to exchange the existing sheath for a 6 French or
8 French closure sheath. While applying pressure, the
device shaft was rotated into the subcutaneous tissue and
then it was positioned into the artery. Once arterial
placement was confirmed by pulsatile blood flow through
the marker lumen, in the case of Angio-Seal, the collagen
suture weave was centered and compacted onto the
extravascular surface at the arteriotomy site. In the case of
the Closer S, the needles of the device were deployed and
they captured the sutures, which were tied with a knot-
tying device called a clincher. Once the knot was prelimi-
narily tied above the skin level, the clincher was removed
and the knot was clinched down onto the artery.
All the patients receiving closure devices in this study
were required to remain in a supine position in bed for two
hours. However, the patients who were unable to
ambulate due to their disease or their unconsciousness, or
if they required subsequent surgery or procedures, or if
they did not wish to ambulate, they were then kept in bed
for more than two hours. 
Study Population
Over an 18-month period from March 28, 2003 to
August 31, 2004, all the patients who underwent diagnos-
tic angiography or endovascular interventional treatment
at Samsung Medical Center (SMC) received detailed
information about the closure devices prior to the
procedure. Among them, 1,221 patients with 1,723 cases
of diagnostic angiography or endovascular intervention
provided written informed consents for the application of
closure devices. However 41 patients with 47 cases of
diagnostic angiography or endovascular intervention who
displayed contraindications for the closure devices were
excluded: 31 cases had difficulty in puncture, three had
marked obesity and 13 had severe atherosclerotic stenooc-
clusive disease. Finally, 1,676 cases (961 with Angio-Seal,
715 with the Closer S) in 1,180 patients were enrolled in
this study. The interventional radiologists and neuroradiol-
ogists at SMC had experience with 322 cases of Angio-Seal
and 97 cases of the Closer S prior to beginning this study.
All the enrolled patients were randomized to either the
Angio-Seal group or the Closer S group at the end of the
angiography procedure or after the endovascular interven-
tional procedure.
All the patients were closely monitored for 24 hours
after the procedure. After one month, they received
follow-up examinations by their physician or they were
contacted over the telephone to assess the status of the
puncture sites.
Definitions
All the definitions had been formulated in previously
published studies (9, 12). Immediate hemostasis was
defined as complete hemostasis after the deployment of
the device, either with or without the need for additional
manual compression within three minutes from the start of
the procedure. Major complications were defined as
follows: the need for vascular surgery, hemorrhage requir-
ing transfusion, pseudoaneurysm, arteriovenous fistula,
arterial occlusion or distal arterial embolism, and infections
necessitating treatment with intravenous antibiotics or
surgical debridement. Minor complications included any
hemorrhage from the puncture site that was controlled via
conservative management without transfusion (i.e.
additional manual compression, sandbag placement or
prolonged bed rest), and infections that could be treated
with oral antibiotics. Moreover, all the complications were
categorized as either early or late. Early complications
were those that occurred within 24 hours, and late compli-
cations were those that occurred at least 24 hours after the
procedure. Therefore, successful vascular device closure
was defined as immediate hemostasis without complica-
tions.
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The demographic and clinical outcome data were
prospectively collected using a standardized “procedural
data sheet for the closure device” and the data were
recorded on the day that the procedure was performed, 24
hours afterward and at one month, or at the time when the
complications were noted. The procedural data included
the type of intervention, the procedure data, sheath size,
the procedure-related drug dose and the number of
previous punctures. Major or minor complications, as well
as the time of events, were also recorded. 
All the categorical variables were analyzed using chi-
square tests and Fisher’s exact tests in order to determine
the statistical differences. p values < 0.05 were considered
to be statistically significant.
RESULTS
One thousand six hundred and seventy-six femoral
arterial closure devices were used in 1,180 patients, and
these cases constituted the basis for this study.
The demographics regarding the two patients groups
undergoing diagnostic and interventional catheterization
were comparable (Table 1). The most frequent procedures
were transarterial chemoembolization (TACE) for the
endovascular interventional treatment and transfemoral
cerebral angiography (TFCA) for the diagnostic angiogra-
phy. There were no statistical differences between the two
groups with regard to gender, age, the underlying disease
including diabetes and hypertension, smoking or the sizes
of the arterial sheaths.
Efficacy (Table 2)
Angio-Seal (n = 961) was successful in 915 cases and this
corresponds to a 95.2% immediate hemostasis rate, and
Angio-Seal was unsuccessful in 46 cases for a 4.8% failure
rate for immediate hemostasis. Some complications
occurred in 25 cases for a 2.6% complication rate, so
success with the closure device was achieved in 890 cases
for a 92.6% success rate. The Closer S (n = 715) was
successful in 640 cases for an 89.5% immediate hemostasis
rate, and the Closer S was unsuccessful in 75 cases for a
10.5% failure rate for immediate hemostasis. Some
complications occurred in 12 of the Closer S cases for a
1.7% complication rate, and success of the closure device
was achieved in 628 cases for a 87.8% success rate.
Differences in the immediate hemostasis rates and the
overall success rates between the two groups were found
to be statistically significant (p < 0.05). There were no
complications in the cases of immediate hemostasis failure
in both groups.
Failure of Immediate Hemostasis
When continuous bleeding occurred after device deploy-
ment, the patients were treated with standard manual
compression until hemostasis was achieved, after which the
patient was instructed to take five to eight hours of bed
rest. Angio-Seal was associated with 46 cases of unsuccess-
ful immediate hemostasis, and the Closer S was associated
with 75 cases of unsuccessful immediate hemostasis. Most
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Table 2. Efficacy and Complications
Angio-Seal (n = 961) The Closer S (n = 715) p
Immediate hemostasis 915 (95.2%) 640 (89.5%) p < 0.05
Failure of immediate hemostasis 046 075
Total complication 025 (2.6%) 012 (1.7%) NS
Early complications 019 009
Late complications 006 003
Successful device closure rate 092.6% 087.8% p < 0.05
Note.─ NS = not significant
Table 1. Baseline Demographics (1,676 cases in 1,180
patients)
Angio-Seal  The Closer S 
(n = 961) (n = 715)
Male 727 (75.7%) 435 (60.8%)
Female 234 (24.3%) 280 (39.2%)
Age 15-89 (M:56.8) 16-86 (M:51.1)
Diabetes Mellitus 228 (23.7%) 177 (24.8%)
Hypertension 245 (25.5%) 177 (24.8%)
Smoking 233 (24.2%) 177 (24.8%)
Introducer size
5 French 026 (2.7%) 014 (2.0%)
6 French  782 (81.4%) 586 (82.0%)
7 French 035 (3.6%) 019 (2.7%)
8 French  118 (12.3%) 096 (13.5%)
Interventional treatment 798 (83.0%) 521 (72.9%)
Diagnostic angiography 163 (17.0%) 194 (27.1%)
Previous puncture 672 (69.9%) 234 (32.7%)
Anticoagulant, thrombolytics 042 (4.4%) 066 (9.2%)
Note.─ M = meanof the reasons for failure were device-related in the Angio-
Seal group, whereas the failures tended to be technique-
related in the Closer S group. The causes of the 121
failures are listed in Table 3. The reasons for failure were
not apparent in 28 cases of the Angio-Seal group and in 11
cases of the Closer S group.
Learning Curve (Fig. 1) 
The 18 months of the study period were divided into
quartiles and we analyzed the immediate hemostasis rate
for the quartiles. The immediate hemostasis rates of the
two devices showed a rising curve over the study period.
The immediate hemostasis rate was not significantly differ-
ent during the four quartile (97.8% in the Angio-Seal
group and 96.1% in the Closer S group, p > 0.05),
although it was significantly different during the first
quartile (93.5% in the Angio-Seal group and 82.5% in the
Closer S group, p < 0.05). 
Complications
Twenty-five complications occurred in the Angio-Seal
group. Three cases (0.3%) were major complications, and
22 cases (2.3%) were minor. Twelve complications
occurred in the Closer S group, and we observed four
major complications (0.6%) and eight minor complications
(1.1%). Any statistically significant differences with regard
to the major and minor complications between the two
groups were not noted. All the major and minor complica-
tions are shown in Tables 4 and 5.
1) Angio-Seal 
All the major complications developed at least 24 hours
after the procedure. There was one case (0.1%) of local
groin infection, which was a soft tissue infection with pus
formation. This infection was treated successfully with
intravenous vancomycin
� (CJ). In one case (0.1%), the
patient developed a cellulitis-associated pseudoaneurysm
that was treated successfully via manual compression and
intravenous cefazolin
� (ChongKunDang Pharm, Seoul,
Korea). In one case (0.1%), a right common femoral artery
occlusion developed (Fig. 2). This patient received TACE
through the right common femoral arterial puncture
because of his hepatocellular carcinoma associated with
liver cirrhosis. The right common artery occlusion was
detected in the next month when an additional TACE
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Fig. 1. Learning Curve
Table 3. Causes for Failure of Immediate Hemostasis
Angio-Seal (n = 46) The Closer S (n = 75)
Inadequate collagen plug 05 Failure of capture suture 34
Broken sheath 04 Broken suture 15
Technique-related 02 Failure to advance knot 09
Device malfunction 07 Device malfunction 04
Cause not apparent 28 Iliac tortuosity 02
Cause not apparent 11
Table 4. Major Complication
Angio-Seal The Closer S p
Early complication (< 24 hours)
Hemorrhage requiring transfusion 0 1* (0.1%)
Late complication (> 24 hours)
Infection 1**(0.1%) 0
Arterial occlusion 1 (0.1%) 0
Pseudoaneurysm 1 (0.1%) 3***(0.4%)
Overall rate 3 (0.3%) 4 (0.6%) NS
Note.─ NS = not significant, *need for vascular surgery, **intravenous antibiotics due to soft tissue infection, ***thrombin injection procedure was attempted. Because collateral circulation
had already been well developed without any symptoms,
as evidenced by the right common femoral arteriogram,
there was no necessity for any additional interventional
procedures. 
All minor complications were cases of groin
hemorrhages. There were 19 early cases (2.1%) and three
late cases (0.2%). All of the early complications were
controlled by manual compression or prolonged bed rest.
In all of the late complications, the patients developed
hemorrhage within 5 days of discharge. Two patients did
not warrant readmission and the hemorrhage stopped after
the patient changed the dressing at his or her home. One
patient visited the emergency room, but the hemorrhage
stopped subsequent to manual compression, and no blood
transfusion was required.
2) The Closer S
Of four major complications that occurred for the Closer
S device, only one case (0.1%) was observed to develop
within 24 hours. Massive retroperitoneal hemorrhage and
hypovolemic shock developed. The patient underwent
surgical repair and blood transfusion. Three cases (0.4%)
were pseudoaneurysm cases, and one of these cases was
associated with local groin infection; it was successfully
treated with intravenous vancomycin
� (CJ). One of these
cases was treated by thrombin injection (Fig. 3), and the
other was treated by manual compression.
All minor complications developed within 24 hours of
the procedures. Hemorrhages developed in eight cases
(1.1%). Blood transfusion was not necessary, and manual
compression or prolonged bed rest proved sufficient.
Previous Arterial Puncture
In 672 cases (69.9%), the patients treated with the
Angio-Seal device had undergone at least one prior
femoral arterial puncture. In 234 cases (32.7%), the
patients treated with the Closer S device had undergone at
Park et al.
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Fig. 2. Right common femoral artery
occlusion (white arrow) in a 63-year-old
woman receiving Angio-Seal at one
month after transarterial chemoem-
bolization. 
A. Right femoral arteriography.
B. Collateral circulation has already
developed.
AB
Table 5. Minor Complication
Angio-Seal The Closer S p
Early complication (< 24 hours)
Hemorrhage* 19 (2.1%) 8 (1.1%)
Late complication (> 24 hours)
Hemorrhage* 03 (0.2%) 0
Overall rate 22 (2.3%) 8 (1.1%) NS
Note.─ NS = not significant, *rebleeding requiring conservative management without transfusion least one prior femoral arterial puncture. In both groups,
the outcomes for these patients were similar to those of the
patients who had undergone the first femoral arterial
puncture (Table 6).
DISCUSSION
Prior to the advent of vascular closure devices, manual
or mechanical compression with the subsequent applica-
tion of a pressure bandage constituted the standard
technique for the management of femoral access sites after
performing diagnostic and interventional catheterizations.
However, this traditional femoral access site treatment
required prolonged immobilization, as well as significant
patient discomfort (11). Immediate removal of the arterial
sheath and achieving hemostasis of the femoral access site
after such procedures tends to improve patient comfort, as
well as save time, and this reduces the workload for the
medical staff and reduces the length of hospital stays.
Several vascular closure devices have gained market
approval in the past few years. Representative of these
devices are the collagen plug device called Angio-Seal and
the suture-mediated device called the Closer S. To our
knowledge, there hasn’t been any prospective comparison
trial between these two types of closure devices.
In this study, we collected prospective data to compare
Prospective Comparison of Collagen Plug and Suture-Mediated Closure Devices at Femoral Access Sites
Korean J Radiol 6(4), December 2005 253
Fig. 3. A pseudoaneurysm (arrow) in a 57-year-old man who received the Closer S at 1 week after TACE. 
A. Right common femoral CT angiography.
B. Right common femoral angiography.
C. A pseudoaneurysm was treated by thrombin injection.
AB C
Table 6. Comparison between First (I) and Repeated Punctures (II)
Angio-Seal The Closer S
II Ip II Ip
Immediate hemostasis 93.8% 95.8% NS 90.5% 87.6% NS
Complication rate 4.2% 1.9% NS 1.2% 2.6% NS
Overall rate 89.6% 93.9% NS 89.2% 85.4% NS
Note.─ NS = not significantthe outcomes of the Angio-Seal and the Closer S devices.
We have demonstrated that the immediate hemostasis
rates and the overall success rates of Angio-Seal were
statistically higher than those of the Closer S. The
incidence of immediate hemostasis was 915/961 (95.2%)
in the Angio-Seal group and 640/715 (89.5%) in the
Closer S group. However, the incidence of complications
was 25/961 (2.6%) in the Angio-Seal group and 12/715
(1.7%) in the Closer S group. However, when comparing
the immediate hemostasis rates according to the successive
quartile, there was no significant difference during the
fourth quartile (97.8% in the Angio-Seal group and 96.1%
in the Closer S group, p > 0.05), although there was a
significant difference during the first quartile (93.5% in the
Angio-Seal group and 82.5% in the Closer S group, p <
0.05). The Closer S requires quite a longer time until an
operator is accustomed to using the Closer S because the
Closer S is more difficult and complicated to use as
compared with Angio-Seal. Therefore, such disadvantage
of the Closer S could decrease its efficacy at first. 
The complication rates between the two groups were not
determined to be significantly different. Defects in the
devices themselves, as well as some variables associated
with the patients, may have also had some effect on the
efficacy of the two devices, although this was not analyzed
in our study.
Previous studies regarding the use of compressive
hemostatic techniques have reported widely varying
vascular complication rates following invasive cardiac
procedures, and these have been in the range of 0.2% to
10.6% (13-20). The complication rates reported by the
present study are at the lower end of this range.
Comparisons among these studies are confounded by
interstudy variability with regard to many methodological
factors, and the most important of which may be the way
in which the complications are defined. For example, in
one large interventional series (13), hematomas were
considered to be a complication only if a 15% decrease in
the hematocrit was detected, or in the cases in which
surgical repair was required. In the same study, infections
were considered as complications only when the patients
required intravenous antibiotics or surgery. Compared
with the previous studies, we used a very broad definition
for complications.
A low rate of major complications was also reported in
association with the use of both the collagen plug devices
and the suture closure devices (12, 14, 18). In this prospec-
tive study, the incidence of major complications in the
Angio-Seal group and the Closer S groups were 0.3% and
0.6%, respectively, which is well within the range reported
in the published data (8-12). When comparing all the
Angio-Seal and the Closer S cases, we detected no statisti-
cal differences in the major complications between the two
devices. In the case of femoral arterial occlusion in the
Angio-Seal group, the anchor of the device, which remains
in the intraarterial lumen after the deployment of the
device, may increase the risk of arterial occlusion or distal
arterial embolism. Also, this can be accelerated with the
application of additional manual compression. In the case
of infection in the Closer S group, the patient was treated
by vascular surgery, unlike the infection cases in the
Angio-Seal group who were successfully treated with only
intravenous antibiotics. The nonabsorbable suture material
used in the Closer S system remains in the intraarterial
lumen after the deployment of the device, and it may
induce foreign body reactions, as well as vascular inflam-
mation and necrosis. In the case involving massive
retroperitoneal hemorrhage in the Closer S group, the
patient had performed excessive hip motion of the lower
extremities after being allowed to ambulate, and this
motion broke the knots and suture. To prevent this
accident, it is necessary to put limitations on the patient for
excessive motion of the lower extremity such as perform-
ing a knee-to-the-chest posture. 
The incidence of minor complications was 22/961 (2.3%)
in the Angio-Seal group and 8/715 (1.1%) in the Closer S
group. This was also found to not be statistically different
between the two devices. These percentages are lower
than those that have been reported for minor complica-
tions in the literature, which have ranged from 4% to 23%
(3, 5, 14). The wide range of variability in terms of the
reported minor complications is probably attributable to
the differences in definitions between the trials, such as the
threshold for reporting a groin ooze or a very small
hematoma. In this study, slow oozing of blood from the
access site that required no additional treatment was
excluded as a minor complication. That is why our study
reported such a remarkably low incidence of minor
complications as compared with prior studies. However,
when using the same definitions for both the Angio-Seal
and the Closer S groups, we found no differences between
the two devices in this regard.
Closure devices were safely used in patients who had
undergone previous femoral arterial punctures, including
those patients who had undergone the deployment of
previous closure devices. There were no statistically signifi-
cant differences between the first and repeated femoral
arterial puncture subgroups, in both the Angio-Seal and
Closer S groups.
In addition to complications, the primary disadvantage of
closure devices is the local discomfort during or after the
procedure. However, our patients did not complain of
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discomfort for at least 24 hours after the procedure, and
the restriction on ambulation and discomfort during the
use of standard compressive therapy tends to compensate
for the discomfort inherent to this procedure. Finally, the
closure devices tend to increase the cost of the catheteriza-
tion procedure. Whether this cost will be offset by reduced
complications requires more specific study.
The limitation of this study was that there was a differ-
ence of 246 cases between the two groups, although this
was randomized. In our center, 322 Angio-Seal devices
were used at the beginning of the study before the Closer S
device was used. Since interventional radiologists and
neuroradiologists tried to use both devices to avoid a bias
for choosing between the two devices for a patient, the
difference in the number of cases did exist. 
In conclusion, the use of Angio-Seal was found to be
more effective than that of the Closer S for the hemostasis
of femoral access sites. Angio-Seal is easier to use and it
requires a shorter learning time than does the Closer S.
There were no differences found with regard to the rates of
complications between the Angio-Seal and the Closer S
groups.
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